Nagy et al.
Time-sensitive US update: FDA briefing documents published in May 2026 proposed that BPC-157 and TB-500-related substances should not be added to the US 503A Bulks List
Similarly, studies suggested that ZIP5 protein and mRNA expression was highest in ESCC, intermediate in paraneoplastic tumors, and lowest in normal tissue
For example, the REWIND trial revealed that dulaglutide may reduce the risk of cognitive decline in patients with T2DM (Cukierman-Yaffe et al., 2020
Towards the design of carnitine acyltransferase inhibitors: Modeling the confor- mational behavior of (r)-carnitine, (r)-acetylcarnitine, Morpholinium rings, and 2-oxo-1,3,6-dioxaza- phosphacinium rings, disertacin de doctorado en Qumica, Virginia Polytechnic Institute and State University, USA